![]() |
Volumn 23, Issue 9, 2016, Pages 285-286
|
Mesenchymal stem cell: A new horizon in cancer gene therapy
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CYCLIN D2;
CYTOKINE;
BIOLOGICAL MARKER;
ARTICLE;
CANCER GENE THERAPY;
CELL SURVIVAL;
DRUG DELIVERY SYSTEM;
GENE DELIVERY SYSTEM;
GENE VECTOR;
MESENCHYMAL STEM CELL;
MOLECULARLY TARGETED THERAPY;
PRIORITY JOURNAL;
TROPISM;
TUMOR CELL;
TUMOR MICROENVIRONMENT;
ANIMAL;
APOPTOSIS;
BIOLOGICAL THERAPY;
CYTOLOGY;
GENE EXPRESSION REGULATION;
GENE THERAPY;
GENE TRANSFER;
GENETICS;
HUMAN;
MESENCHYMAL STEM CELL TRANSPLANTATION;
MESENCHYMAL STROMA CELL;
METABOLISM;
NEOPLASM;
SIGNAL TRANSDUCTION;
ANIMALS;
APOPTOSIS;
BIOMARKERS;
CELL SURVIVAL;
CELL- AND TISSUE-BASED THERAPY;
GENE EXPRESSION REGULATION;
GENE TRANSFER TECHNIQUES;
GENETIC THERAPY;
HUMANS;
MESENCHYMAL STEM CELL TRANSPLANTATION;
MESENCHYMAL STROMAL CELLS;
NEOPLASMS;
SIGNAL TRANSDUCTION;
|
EID: 84988654396
PISSN: 09291903
EISSN: 14765500
Source Type: Journal
DOI: 10.1038/cgt.2016.35 Document Type: Article |
Times cited : (100)
|
References (10)
|